Paper Details

  1. Home
  2. Paper Details

Overcoming platinum resistance in ovarian carcinoma.

Author: LinYvonne G, MatsuoKoji, RomanLynda D, SoodAnil K

Research Support, U.S. Gov't, Non-P.H.S.Research funding provided by US government agencies other than the Public Health Service.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Ovarian cancer is a serious disease because it often returns after initial treatment and becomes resistant to chemotherapy, including platinum-based drugs. There is no standard treatment for ovarian cancer that has become resistant to platinum, as current options have similar, but unfortunately low, success rates.
Paper Details　
Original Abstract of the Article :
Ovarian cancer remains a deadly malignancy because most patients develop recurrent disease that is resistant to chemotherapy, including platinum. Because response rates for current treatment regimens are relatively similar and unfortunately low, no standard chemotherapy for platinum-resistant ovaria...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/20815774

データ提供：米国国立医学図書館（NLM）

Battling Platinum Resistance in Ovarian Cancer

Ovarian cancer is a challenging disease, and many patients develop resistance to platinum-based chemotherapy drugs, which are often used to treat it. This article explores the problem of platinum resistance and the need for new treatment strategies. Think of it like facing a sandstorm that is becoming more intense and difficult to navigate. The old strategies for protection are no longer effective, and new solutions are needed.

The article highlights the need for new treatments that can overcome platinum resistance. Researchers are actively working to develop new drugs and therapies that can effectively target ovarian cancer cells, even when they have become resistant to platinum-based chemotherapy. Think of it like searching for a new route through the desert that avoids the most dangerous sandstorms and leads to a safe haven.

Finding New Ways to Fight Cancer

The search for new treatments for platinum-resistant ovarian cancer is a critical area of research. This research could lead to more effective therapies for patients who have exhausted other treatment options. Think of it like finding a new source of water in the desert, which can sustain life and bring hope to a parched land.

Hope for Ovarian Cancer Patients

The ongoing research into platinum-resistant ovarian cancer is bringing new hope for patients who are facing this challenging disease. Researchers are determined to find new ways to fight cancer and improve the outcomes for patients. Think of it like the enduring spirit of the desert dwellers, who are constantly seeking new ways to overcome the challenges of their environment and thrive.

Dr. Camel's Conclusion

This article highlights the urgent need for new treatments that can overcome platinum resistance in ovarian cancer. Think of it like facing a sandstorm that is becoming more intense and difficult to navigate. The old strategies for protection are no longer effective, and new solutions are needed. The search for these new solutions is a critical area of research, bringing hope to patients who are facing this challenging disease.

Date :
  1. Date Completed 2011-04-21
  2. Date Revised 2023-02-02
Further Info :

Pubmed ID

20815774

DOI: Digital Object Identifier

NIHMS229006

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.